rxstat › Shortages › Drospirenone Ethinyl Estradiol

Drospirenone Ethinyl Estradiol shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Drospirenone Ethinyl Estradiol products are in shortage in Canada (1 of 9 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 10, 2026.
Products affected
1 of 9
In shortage since
Apr 16, 2026
Est. full return
Aug 10, 2026
Reports on file
29
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28
3MG 0.03MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02421445 · since Apr 16, 2026, est. end Aug 10, 2026 · Demand increase for the drug.
Resolved
MYA
0.02MG 3.00MG · TABLET · APOTEX INC
DIN 02415380 · ended Mar 5, 2026 · Disruption of the manufacture of the drug.
Resolved
YASMIN 28
3MG 0.03MG · TABLET · BAYER INC
DIN 02261731 · ended Mar 3, 2026 · Other (Please describe in comments)
Resolved
MYA
0.02MG 3.00MG · TABLET · APOTEX INC
DIN 02415380 · ended Feb 12, 2026 · Disruption of the manufacture of the drug.
Resolved
ZAMINE 28
0.03MG 3MG · TABLET · APOTEX INC
DIN 02410796 · ended Jan 22, 2026 · Disruption of the manufacture of the drug.
Resolved
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP
3MG 0.02MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02462060 · ended Dec 12, 2025 · Disruption of the manufacture of the drug.
Resolved
ZAMINE 28
0.03MG 3MG · TABLET · APOTEX INC
DIN 02410796 · ended Dec 4, 2025 · Disruption of the manufacture of the drug.
Resolved
MYA
0.02MG 3.00MG · TABLET · APOTEX INC
DIN 02415380 · ended Nov 6, 2025 · Disruption of the manufacture of the drug.
Resolved
ZAMINE 28
0.03MG 3MG · TABLET · APOTEX INC
DIN 02410796 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.
Resolved
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21
0.03MG 3MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02421437 · ended Aug 12, 2025 · Disruption of the manufacture of the drug.
Resolved
MYA
0.02MG 3.00MG · TABLET · APOTEX INC
DIN 02415380 · ended May 15, 2025 · Disruption of the manufacture of the drug.
Resolved
MYA
0.02MG 3.00MG · TABLET · APOTEX INC
DIN 02415380 · ended Feb 27, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 29 reports. All reports are on file with Health Canada.

What's happening

Drospirenone Ethinyl Estradiol is currently affected by an active shortage report filed with Health Canada by GLENMARK PHARMACEUTICALS CANADA INC..

The reported cause is: demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Drospirenone Ethinyl Estradiol is classified under “HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE” (ATC G03AA).

Recent changes

Common questions

When will Drospirenone Ethinyl Estradiol be back in stock in Canada?

The latest manufacturer estimate is Aug 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Drospirenone Ethinyl Estradiol in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (hormonal contraceptives for systemic use)

Partial shortageEthinyl Estradiol Desogestrel1 of 10 reported products affected · est. return Aug 20, 2026Partial shortageEthinyl Estradiol Levonorgestrel3 of 18 reported products affectedPartial shortageEthinyl Estradiol Levonorgestrel Ethinyl Estradiol1 of 1 reported products affectedPartial shortageEthinyl Estradiol Norethindrone4 of 10 reported products affected · est. return Mar 19, 2027Partial shortageNorethindrone1 of 4 reported products affected · est. return Aug 10, 2026Partial shortageNorgestimate Norgestimate Norgestimate Ethinyl Estradiol Ethinyl Estradiol Ethinyl Estradiol2 of 10 reported products affected

All hormonal contraceptives for systemic use shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.